Skip to main content
. 2018 Mar 9;91(1091):20170969. doi: 10.1259/bjr.20170969

Table 1.

Established theranostic agents in current use in the clinic

Clinical indication Diagnostic agent Therapeutic agent
Hyperthyroidism or thyroid cancer 123I-iodide 131I-iodide
Adrenergic tumours 123I-iobenguane 131I-iobenguane
Bone metastases from prostate cancer 99mTc-MDP 223Ra chloride
Non-Hodgkins lymphoma 111In-ibritumomab 90Y-ibritumomab
Neuroendocrine tumours 68Ga-DOTATATE 177Lu-DOTATATE
Prostate cancer 68Ga-DKFZ-PSMA-11 177Lu-DKFZ-PSMA-617